Autoimmune Afib; Inappropriate ICD Shocks Down; Dissolving Cardiac Sensors

(MedPage Today) -- FDA approved expanded use of inclisiran (Leqvio) for primary hyperlipidemia atop its existing indications of atherosclerotic cardiovascular and heterozygous familial hypercholesterolemia, Novartis announced. An estimate gives...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news